The storied success of Viagra has undeniably transformed the drug landscape. However, investing in companies heavily dependent on biosimilars and the declining patent protection surrounding this flagship https://get-social-now.com/story6832660/the-blue-pill-and-pharmaceutical-companies-a-risky-investment